Table 1 Characteristics of the study group
Number of patients | % of patients | |
|---|---|---|
Clinical stage based on DRE | ||
cT1 | 40 | 19.7 |
cT2a | 40 | 19.7 |
cT2b | 119 | 58.6 |
cT2c | 4 | 2 |
Clinical stage based on MRI | ||
iT0 | 7 | 3.4 |
iT2a | 35 | 17.2 |
iT2b | 40 | 19.7 |
iT2c | 86 | 42.4 |
iT3a | 10 | 4.9 |
iT3b | 5 | 2.5 |
Missing | 20 | 9.9 |
PIRADS category in MRI | ||
PIRADS 3 | 29 | 15,8 |
PIRADS 4 | 86 | 47 |
PIRADS 5 | 61 | 33,3 |
BCR risk according to EAU criteria | ||
Low | 29 | 14.3 |
Intermediate | 151 | 74.4 |
High | 23 | 11.3 |